A Double-blind, Placebo-controled, Crossover Study To Evaluate the Efficacy, Safety and Tolerability of Inhaled ASM8-003 in Subjects With Mild Allergic Asthma.

Next Previous
Trial Profile

A Double-blind, Placebo-controled, Crossover Study To Evaluate the Efficacy, Safety and Tolerability of Inhaled ASM8-003 in Subjects With Mild Allergic Asthma.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 20 Dec 2012

At a glance

  • Drugs ASM 8 (Primary)
  • Indications Allergic asthma
  • Focus Therapeutic Use
  • Sponsors Pharmaxis

    • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 11 Sep 2007 Status changed from in progress to completed.
    • 14 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top